Spectral AI, Inc. (NASDAQ:MDAI) shares are trading higher Friday. The company announced the enrollment of the first patient in a study to validate DeepView AI for burn injuries on Thursday.
What To Know:
Spectral AI said that the study will utilize its imaging technology for burn size and healing assessment and will be the final clinical trial before seeking FDA marketing authorization for the burn indication in 2025.
“We believe this study will further demonstrate the truly innovative and versatile nature of our technology, as well as its ability to predict burn wound healing potential on the first day of injury with significantly greater accuracy and speed than the methods currently used today,” said Niko Pagoulatos, Ph.D., COO of Spectral AI.
“We continue to utilize $251 million of non-dilutive government funding since 2019 to validate DeepView for burn indication, while aggressively advancing other clinical indications like diabetic foot ulcers in pursuit of our ‘one platform—multiple clinical indications’ strategy.”
Spectral AI shares are climbing on heavy volume Friday with more than 15.3 million shares already traded in the session. According to data from Benzinga Pro, the stock has a 100-day average volume of just under 972,000 shares.
Related News: What’s Going On With Obesity Drug-Developer Altimmune Inc Stock?
MDAI Price Action: According to Benzinga Pro, Spectral AI shares are up 23.5% at $3.15 at the time of publication.
Image: Peace,love,happiness from Pixabay
